June 27, 2023
QUARTERLY IN DEPTH INVESTMENT ANALYSIS – CYBIN INC (NYSE: CYBN)
This quarter I am going to be covering a Biotech name that I feel, after extensive due diligence and interviewing members from the executive team (including the CEO, Doug Drysdale) is in a good position to gain additional market share and growth in the short and medium term.
Share: